As part of LWP’s value add to the life science community, we are going to conduct a survey of big pharma/biotech BD, venture backed biotech CEO/CBO/VP BD, publicly traded biotech CEO/CBO/VP BD, and life science VCs about their thoughts on the state of the business develompent market. Most investment banks put together equity capital market conditions and M&A overviews but no one to what I’ve seen has put together deep insight into the BD market. Firms like Burrill & Co and ReCap often publish data but we want to go another layer below. Hopefully you’ll be receptive to our survey and will find useful the results that we share. We’ll give the full results to people who participate but only an executive summary released publicly.

If you have suggestions on what questions you’d want answered or specific things of interest, feel free to email me at geoff@locustwalkpartners.com with suggestions.